Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1992-6-22
pubmed:abstractText
Amphotericin B (AmB) has toxic effects and alters neutrophil (polymorphonuclear leukocyte [PMN]) function. A lipid-complexed formulation of AmB (AmB-LC) has been reported (A. S. Janoff, L. T. Boni, M. C. Popescu, S. R. Minchey, P. R. Cullis, T. D. Madden, T. Taraschi, S. M. Gruner, E. Shyamsunder, M. W. Tate, R. Mendelsohn, and D. Bonner, Proc. Natl. Acad. Sci. USA 85:6122-6126, 1988) to be less toxic than a desoxycholate-suspended preparation of AmB (AmB-des; Fungizone). In this study we compared the effects of AmB-des and AmB-LC on in vitro PMN function. Neither form of AmB stimulated PMN chemiluminescence, but AmB-des (2 micrograms/ml) nearly tripled PMN chemiluminescence in response to f-Met-Leu-Phe (fMLP), a phenomenon known as priming. Because AmB stimulates monocytes to release cytokines which can affect PMN function, we studied the effects of AmB on PMNs in mixed leukocyte cultures. AmB-des (1 to 2 micrograms/ml) increased the chemiluminescence of PMNs plus mixed mononuclear leukocytes (MNLs) to fMLP. The activity was about three times that of PMNs plus MNLs and seven times the activity of PMNs stimulated with fMLP in the absence of MNLs. Cell-free AmB-des (2 micrograms/ml)-stimulated, MNL-conditioned medium primed pure PMNs to a level equal to that of whole MNLs treated with AmB-des. AmB-LC was much less potent. AmB-LC (20 micrograms/ml) increased fMLP-stimulated chemiluminescence to two times that of PMNs plus MNLs without AmB-LC. AmB-des (2 micrograms/ml) (but not AmB-LC [2 micrograms/ml]) increased nitroblue tetrazolium reduction by PMNs in whole blood from 31 to 52% of positive cells. Neither form of AmB increased Mac-1 (the CD11b/CD18 integrin) expression of pure PMNs. AmB-des (0.5 to 2 micrograms/ml) (but not AmB-LC [< or = 40 micrograms/ml]) nearly doubled PMN Mac-1 expression in the presence of MNLs, and cell-free AmB-des (2 micrograms/ml)-stimulated, MNL-conditioned medium stimulated PMN Mac-1 to 125% of the control level. AmB-des (0.2 to 2 micrograms/ml) (but not AmB-LC [< or = 40 micrograms/ml]) decreased chemotaxis of pure PMNs to fMLP by as much as 35% and that of PMNs in the presence of MNLs by as much as 50%. Desoxycholate by itself had no effect on PMN function. These differences in activity between AmB-des and AmB-LC may explain the lessened toxicity observed with AmB-LC.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-1102606, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-1259763, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-1649568, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-1856491, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2069367, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2088196, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2112579, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2157668, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2170522, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2183713, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2324537, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2540256, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-2909629, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-3031189, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-309132, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-3110308, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-3245698, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-3292277, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-3339245, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-3413081, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-4384563, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-4768939, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-6275780, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-6286769, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-6289729, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-6842027, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-7430646, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-836011, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-900919, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-947845, http://linkedlifedata.com/resource/pubmed/commentcorrection/1590697-965486
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
39-45
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).
pubmed:affiliation
Department of Medicine, University of Virginia, Charlottesville 22908, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't